Family Site
Subsidiary
Pharma·Bio
Ship · Plant · Energy
Life · Health · Leisure
Finance

ESG

Governance Structure

  • Shareholders
  • Board of Directors
  • Article of Incorporate
  • Ethical Management
  • Anti-corruption Management
  • Others

Corporate Governance Charter

HLB Therapeutics will establish a corporate governance charter to define the correct management direction and enhance its reputation as a trusted company. Through this charter, we aim to share values with various stakeholders, including customers, shareholders, and employees.

ESG Ratings

As of the first half of 2025, our company has been awarded an ESG rating of 'A' overall by SUSTINVEST.

Stock Code Stock Name Asset Size Overall Rating
115450 HLB Therapeutics Co., Ltd. Less than 500 billion KRW A
ESG Rating Table and Distribution
  • Evaluation Period: First half of 2025
  • Basis of Preparation: Scale Rating
Rating Rating Meaning Proportion in 25H1
AA Companies with excellent ESG risk and opportunity management
7.3%
A Companies with outstanding ESG risk and opportunity management
19.9%
BB Companies with very good ESG risk and opportunity management
31.9%
B Companies with satisfactory ESG risk and opportunity management
18.5%
C Companies with average ESG risk and opportunity management
17.3%
D Companies with weak ESG risk and opportunity management
3.5%
E Companies with very weak ESG risk and opportunity management
1.7%

Corporate Governance Differences from Best Practices

HLB Therapeutics Corporate Governance Charter
Item Adopted Note
Introduction of Corporate Governance Charter O Date Adopted : 2022.09.14
Introduction of Employee Code of Ethics O Year Adopted : 2019.11.29
Board Composition (Majority Independent Directors) X 4 Executive Directors, 2 Independent Directors
Separation of CEO and Board Chair O CEO: Ahn Ki-hong, Board Chair: Jin Yang-gon
Official Notice of Board Activities, Attendance, and Voting on Major Issues O Annual report
Cumulative Voting System X
Nomination Committee for Independent Directors X
Compensation Committee X
Audit Committee (All Independent Directors) X Standing Auditor
Rules on Board and Committee Roles and Procedures O Board Regulation Amendment Date : 2022.06.03
Directors' Liability Insurance at Company's Expense O Executive Liability Insurance (Annual Renewal)
Evaluation of Board Activities O
Maintenance of External Auditor Independence O
Certification of Accuracy and Completeness of Financial Reports by CEO and CFO O
Explanation of Differences from Best Practices O Website